Rigel Pharmaceuticals (RIGL) Capital Expenditures (QoQ) (2010 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -61.38% |
| Sep 30, 2022 | 625.00% |
| Jun 30, 2022 | -116.07% |
| Mar 31, 2022 | 1,166.67% |
| Dec 31, 2021 | -112.35% |
| Sep 30, 2021 | -58.23% |
| Jun 30, 2021 | 473.24% |
| Mar 31, 2021 | -85.91% |
| Dec 31, 2020 | 158.46% |
| Sep 30, 2020 | 543.18% |
| Jun 30, 2020 | -107.25% |
| Mar 31, 2020 | -0.65% |
| Dec 31, 2019 | 73.58% |
| Sep 30, 2019 | 206.09% |
| Jun 30, 2019 | -69.50% |
| Mar 31, 2019 | 446.38% |
| Dec 31, 2018 | -55.77% |
| Sep 30, 2018 | -77.19% |
| Jun 30, 2018 | 247.21% |
| Mar 31, 2018 | 271.70% |
| Dec 31, 2017 | -5.36% |
| Sep 30, 2017 | 300.00% |
| Jun 30, 2017 | -65.85% |
| Mar 31, 2017 | 583.33% |
| Dec 31, 2016 | -97.62% |
| Sep 30, 2016 | 12.00% |
| Jun 30, 2016 | -29.91% |
| Mar 31, 2016 | 139.55% |
| Dec 31, 2015 | -56.35% |
| Sep 30, 2015 | 320.55% |
| Jun 30, 2015 | 128.13% |
| Mar 31, 2015 | -84.00% |
| Dec 31, 2014 | 600.00% |
| Sep 30, 2014 | -153.33% |
| Jun 30, 2014 | -57.87% |
| Mar 31, 2014 | 5.95% |
| Dec 31, 2013 | 31.25% |
| Sep 30, 2013 | -48.59% |
| Jun 30, 2013 | -63.17% |
| Mar 31, 2013 | 12.48% |
| Dec 31, 2012 | 56.51% |
| Sep 30, 2012 | -53.06% |
| Jun 30, 2012 | -48.03% |
| Mar 31, 2012 | 750.81% |
| Dec 31, 2011 | -67.02% |
| Sep 30, 2011 | -19.51% |
| Jun 30, 2011 | -18.95% |
| Mar 31, 2011 | -7.33% |
| Dec 31, 2010 | 3.46% |